Paroxetine Tablet, Film Coated, Extended Release
Product Images NDC 68180-646

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Paroxetine (NDC 68180-646). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

66042161 13e0 4385 98a7 3e90c8382685 01

FDA Label Image

66042161 13e0 4385 98a7 3e90c8382685 02

FDA Label Image

66042161 13e0 4385 98a7 3e90c8382685 03

This is a list of drugs with their recommended dosages. The drugs mentioned are Cimetine (300 mg thrice a day), Prensbortisl (100 mg once a day), Penyion (300 mg once a day), Digarin (0.25 mg once a day), and Diazepam (5 mg twice a day). The term "interaction drug" seems to be an incomplete phrase.*

FDA Label Image

66042161 13e0 4385 98a7 3e90c8382685 04

FDA Label Image

66042161 13e0 4385 98a7 3e90c8382685 05

This is a medication called Paroxetine Extended-Release Tablets USP, by Lupin. Each film-coated tablet contains paroxetine hydrochloride hemihydrate USP equivalent to paroxetine 12.5 mg. It contains color additives including FD&C Yellow No. 5 (tartrazine). The usual dosage and storage information is available in accompanying prescribing information. The medication should be dispensed with a medication guide provided separately to each patient. The product should be stored at 25°C (77°F): excursions permitted to 15° to 30°C (59 to 86°F) [see USP Controlled Room Temperature]. The manufacturer is Lupin Pharmaceuticals, Inc. of Baltimore, Maryland, and the medication is manufactured by Lupin Limited of Pithampur (M.P) 454 775, INDIA.*

FDA Label Image

66042161 13e0 4385 98a7 3e90c8382685 06

This is a medication guide for NDC 68180-646-06, which contains paroxetine hydrochloride hemihydrate USP equivalent to paroxetine 25mg. It is an extended-release tablet produced by Lupin Pharmaceuticals. Pharmacists are instructed to dispense with the medication guide provided separately to each patient. The medication should be stored between 15°C to 30°C (59 to 86°F). Physicians should direct the use of safety closures while dispensing it. It also provides the usual dosage and other related information.*

FDA Label Image

66042161 13e0 4385 98a7 3e90c8382685 07

This is a medication description for Paroxetine Extended-Release Tablets. It is advised to dispense with a medication guide provided separately to each patient. It contains Paroxetine hydrochloride hemihydrate USP equivalent to paroxetine 37.5 mg. The recommended usual dosage is specified in the accompanying prescribing information. The medication should be stored at a controlled room temperature of 25°C (77°F) and use safety closures when dispensing unless otherwise directed by the physician or requested by the purchaser. This medication is manufactured for Lupin Pharmaceuticals, Inc. in Baltimore, Maryland, and manufactured by Lupin Limited of Pithampur, India. The text also includes other factual information such as NDC and Rx codes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.